Analysed Indivior Pharmaceuticals, Inc (INDV:NASDAQ) News Sources
A Look At Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After Its Recent Name Change
Yahoo Finance
Indivior outlines 30% adjusted EBITDA growth target for 2026 with new $400M share repurchase program
Seeking Alpha on MSN
India's drug regulator inspected 90% of cough syrup makers, found lapses in some, official says
The Economic Times on MSN
Indoco Remedies receives final ANDA approval from USFDA for Brivaracetam Oral Solution, 10 mg/mL
EquityBulls
Indoco Remedies receives US FDA final approval to market brivaracetam oral solution, 10 mg/mL
Pharmabiz
What is the current price of Indivior Pharmaceuticals, Inc (INDV:NASDAQ)?
The current price of Indivior Pharmaceuticals, Inc (INDV:NASDAQ) is $33.71.
Indivior Pharmaceuticals, Inc (INDV:NASDAQ) absolute price change since previous trading day?
The absolute price change of Indivior Pharmaceuticals, Inc (INDV:NASDAQ) since the previous trading day is $0.08.
Indivior Pharmaceuticals, Inc (INDV:NASDAQ) percentage price change since previous trading day?
The percentage price change of Indivior Pharmaceuticals, Inc (INDV:NASDAQ) since the previous trading day is 0.24%.
What is This Week's average sentiment score for Indivior Pharmaceuticals, Inc (INDV:NASDAQ)?
This Week's average sentiment score for Indivior Pharmaceuticals, Inc (INDV:NASDAQ) is 64 out of 100.
What is This Week's average sentiment for Indivior Pharmaceuticals, Inc (INDV:NASDAQ)?
This Week's sentiment for Indivior Pharmaceuticals, Inc (INDV:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.